Tech Company Financing Transactions

Innovative Biosensors Funding Round

On 5/19/2008, Innovative Biosensors raised $11.5 million in Series B funding from Life Sciences Partners, Chart Venture Partners and CNF Investments.

Transaction Overview

Announced On
5/19/2008
Transaction Type
Debt
Venture Equity
Amount
$11,500,000
Round
Series B
Proceeds Purpose
The new proceeds will be used to accelerate the commercialization of IBI's sensitive, and rapid biosensor-based technology for the detection of hospital and community acquired infections.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
15601 Crabbs Branch Way
Rockville, MD 20855
USA
Email Address
Overview
The BioFlash system is composed of a genetically engineered biosensor that allows for extremely rapid testing of analytes at previously unseen levels of sensitivity and specificity.
Profile
Innovative Biosensors LinkedIn Company Profile
Social Media
Innovative Biosensors Company Twitter Account
Company News
Innovative Biosensors News
Facebook
Innovative Biosensors on Facebook
YouTube
Innovative Biosensors on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Yost
  David Yost LinkedIn Profile  David Yost Twitter Account  David Yost News  David Yost on Facebook
Chief Financial Officer
Rigg Mohler
  Rigg Mohler LinkedIn Profile  Rigg Mohler Twitter Account  Rigg Mohler News  Rigg Mohler on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/19/2008: EoPlex Technologies venture capital transaction
Next: 5/19/2008: MiRagen Therapeutics venture capital transaction

 

Share this article

 


News on VC Transactions

We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary